4//SEC Filing
Walker Luke Nathaniel 4
Accession 0001209191-23-005038
CIK 0001708493other
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 4:05 PM ET
Size
5.6 KB
Accession
0001209191-23-005038
Insider Transaction Report
Form 4
Walker Luke Nathaniel
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-01-24+100,000→ 100,000 totalExercise: $0.89Exp: 2033-01-23→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]25% of the total stock option will vest and become exercisable every six months following the vesting commencement date of January 24, 2023, subject to the continuing employment of the Reporting Person on each vesting date.
Documents
Issuer
Harpoon Therapeutics, Inc.
CIK 0001708493
Entity typeother
Related Parties
1- filerCIK 0001701440
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 4:05 PM ET
- Size
- 5.6 KB